Results 101 to 110 of about 66,673 (183)

Aggressive Systemic Mastocytosis Presenting as Diffuse Osteoblastic Bone Disease: A Diagnostic Pitfall Mimicking Metastatic Cancer. [PDF]

Eur J Case Rep Intern Med
Melício A, Gonçalves HD, Dias M, Vasconcelos-Teixeira S, Madeira Lopes J.   +4 more
europepmc   +1 more source

Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosis. [PDF]

World Allergy Organ J
Pongdee T, Castells M, Akin C, Dybedal I, Gotlib J, Panse JP, Alvarez-Twose I, Cabeza CM, Cerquozzi S, Vadas P, Swarup V, Vachhani P, Wortmann F, Yi CA, Bidollari I, Newberry K, Shaheen D, Hartmann K.   +17 more
europepmc   +1 more source

Hereditary alpha-tryptasemia demonstrates relative basophil enrichment without signs of cellular hyperreactivity. [PDF]

J Allergy Clin Immunol Glob
Johnsson AK, Atanasoai I, Nilsson G, Gülen T.   +3 more
europepmc   +1 more source

Legends of Allergy-Lawrence B. Schwartz. [PDF]

Allergy
Nilsson GP.
europepmc   +1 more source

Comparative Analysis of Pediatric and Adult Mastocytosis: Clinical Presentation, Triggers, and Treatment Patterns from a Tertiary Care Registry. [PDF]

Children (Basel)
NoorSaeed SM, Khalaf R, Alenezi A, Fields E, Prosty C, Alrafiaah AS, Miedzybrodzki B, Netchiporouk E, Sampalis J, Fein M, Ben-Shoshan M.   +10 more
europepmc   +1 more source

Extended multisystem manifestations of hereditary α-tryptasemia in an allergy center cohort. [PDF]

J Allergy Clin Immunol Glob
Koch D, Wortmann F, Recke A, Rose E, Gaffal E, Wigger J, von Bubnoff N, von Bubnoff D.   +7 more
europepmc   +1 more source

Assessing real-world natural history of indolent systemic mastocytosis: A retrospective matched cohort study. [PDF]

J Allergy Clin Immunol Glob
Pongdee T, Powell D, Weis T, Scherber R, Green T, Smither A, Krishnappa P, Carlson K, Singh P, Duff S, Sullivan E.   +10 more
europepmc   +1 more source

Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation. [PDF]

Curr Allergy Asthma Rep
Valent P, Hartmann K, Stefanzl G, Filik Y, Bauer K, Degenfeld-Schonburg L, Gleixner KV, Siebenhaar F, Niedoszytko M, Sperr WR, Aghaallaei N, Hoermann G, Sabato V, Orfao A, Arock M, Akin C.   +15 more
europepmc   +1 more source

Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis. [PDF]

Cureus
Minbaeva S, Tyring SK.
europepmc   +1 more source